429 related articles for article (PubMed ID: 23409948)
1. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
Oyarzún P; Ellis JJ; Bodén M; Kobe B
BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
[TBL] [Abstract][Full Text] [Related]
2. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
[TBL] [Abstract][Full Text] [Related]
3. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
Front Immunol; 2021; 12():598778. PubMed ID: 33717077
[TBL] [Abstract][Full Text] [Related]
4. The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.
Reynolds CJ; Jones C; Blohmke CJ; Darton TC; Goudet A; Sergeant R; Maillere B; Pollard AJ; Altmann DM; Boyton RJ
Immunology; 2014 Nov; 143(3):438-46. PubMed ID: 24891088
[TBL] [Abstract][Full Text] [Related]
5. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
Bordner AJ; Mittelmann HD
BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-cell epitope prediction using antigen processing constraints.
Mettu RR; Charles T; Landry SJ
J Immunol Methods; 2016 May; 432():72-81. PubMed ID: 26891811
[TBL] [Abstract][Full Text] [Related]
7. The immunologic dominance of an epitope within a rationally designed poly-epitope vaccine is influenced by multiple factors.
Shu J; Shen W; Liu H; Zhou Y; Li J; Zhuang Y; Huang Z; Yin S; Jiang L; Sun Y; Jin X; Xu J
Vaccine; 2020 Mar; 38(14):2913-2924. PubMed ID: 32127225
[TBL] [Abstract][Full Text] [Related]
8. Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3.
Consogno G; Manici S; Facchinetti V; Bachi A; Hammer J; Conti-Fine BM; Rugarli C; Traversari C; Protti MP
Blood; 2003 Feb; 101(3):1038-44. PubMed ID: 12393675
[TBL] [Abstract][Full Text] [Related]
9. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
Ribeiro SP; De Moura Mattaraia VG; Almeida RR; Valentine EJG; Sales NS; Ferreira LCS; Sa-Rocha LC; Jacintho LC; Santana VC; Sidney J; Sette A; Rosa DS; Kalil J; Cunha-Neto E
Vaccine; 2022 Jan; 40(2):239-246. PubMed ID: 34961636
[TBL] [Abstract][Full Text] [Related]
10. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands.
Reche PA; Reinherz EL
Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W138-42. PubMed ID: 15980443
[TBL] [Abstract][Full Text] [Related]
11. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
13. A Systematic, Unbiased Mapping of CD8
Stryhn A; Kongsgaard M; Rasmussen M; Harndahl MN; Østerbye T; Bassi MR; Thybo S; Gabriel M; Hansen MB; Nielsen M; Christensen JP; Randrup Thomsen A; Buus S
Front Immunol; 2020; 11():1836. PubMed ID: 32983097
[TBL] [Abstract][Full Text] [Related]
14. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
15. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
[TBL] [Abstract][Full Text] [Related]
16. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
17. In silico prediction of potential vaccine candidates on capsid protein of human bocavirus 1.
Kalyanaraman N
Mol Immunol; 2018 Jan; 93():193-205. PubMed ID: 29207326
[TBL] [Abstract][Full Text] [Related]
18. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
Campi G; Crosti M; Consogno G; Facchinetti V; Conti-Fine BM; Longhi R; Casorati G; Dellabona P; Protti MP
Cancer Res; 2003 Dec; 63(23):8481-6. PubMed ID: 14679013
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cell epitope discovery and rational vaccine design.
Rosa DS; Ribeiro SP; Cunha-Neto E
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):121-30. PubMed ID: 20155490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
